Biotalys granted patents for EVOCA in both Europe and the US

Company Builds Global Intellectual Property Safeguards for Its Crop Protection Pipeline 

Ghent, BELGIUM – 17 September 2024, 07:00 CEST – Biotalys (Euronext BTLS), an Agricultural Technology (AgTech) company developing protein-based biocontrols for sustainable crop protection, today announced that it obtained patentsfor its first biofungicide, EVOCA™*, from both the European Patent Office (EPO) and the United States Patent and Trademark Office (USPTO).

Kevin Helash, Chief Executive Officer of Biotalys, said: “We are very pleased with the recent grants by the European and U.S. patent offices, which follow their thorough examination of our applications protecting the active ingredient of our protein-based biocontrol candidate, EVOCA. These decisions confirm the truly innovative nature of our solution and provide Biotalys with the exclusivity needed to support our commercial partners in producing or distributing EVOCA across Europe and the United States. This will ultimately benefit fruit and vegetable growers seeking to protect their crops against certain fungal diseases.”

In addition, Biotalys has requested patent protection for the product’s active ingredient in countries around the globe, such as Argentina, Brazil, and South Africa, which are compelling markets for crop protection. The company already obtained various patents worldwide on different elements of its technology and is continuously building its intellectual property protection for its products,formulations and processes.

_{*You can download the pdf to read the full press release}